Overcoming Barriers to Access

Our objective is to lower the cost of medicines, vaccines and tests through competition, to ensure patents are not a barrier to access and to push back against harmful trade deals or entrenched industry interests.

12. March 2012
|
INDIA

India Issues First Compulsory Licence

In a landmark case, the Indian Patent Office has issued the first-ever compulsory licence in India to a generic drug manufacturer ending pharmaceutical company Bayer’s monopoly in India on a drug used to treat kidney and liver cancer.

» READ MORE

India 2008 © Jean-Marc Giboux/Getty Images

Access Barriers: The Issues

© Juan Carlos Tomasi

Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.

» Read more

Featured multimedia

UN Rapporteur supports MSF's "Hands Off" Campaign
UN Special Rapporteur on the Right to Health Anand Grover describes just how critical India's role in providing generic medicines to developing countries around the world...

Tags: EU Hands Off Campaign, free trade agreement, India

MSF & Patents

© Julie Remy

MSF created the Access Campaign to help get our patients the best possible treatment which includes looking at the political and commercial barriers that stand in the way of access to affordable medicine.

» Read more

Overcoming Barriers to Access Facts

26 million children – roughly one in five born each year – remained un-immunised globally

» Learn more facts about Overcoming Barriers to Access

↑ To top